Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Antipsychotic Use in Bipolar Disorder

AI Summary
  • Pediatric bipolar disorder causes substantial morbidity, with prolonged symptoms, high suicide attempt rates, increased substance use, and significant psychosocial impairment.
  • Accurate diagnosis requires careful longitudinal assessment because youth often present with rapid cycling, mixed features, and irritability rather than classic euphoric mania.
  • Early diagnosis and timely antipsychotic treatment are critical to reduce impairment and support early recovery in youth with bipolar disorder.
Summarise with AI (MRCPsych/FRANZCP)

Child Adolesc Psychiatr Clin N Am. 2027 Jan;36(1):97-112. doi: 10.1016/j.chc.2026.07.002. Epub 2026 Oct 10.

ABSTRACT

Pediatric (bipolar disorder) BD carries substantial morbidity, including prolonged symptom burden, high rates of suicide attempts and substance use, and psychosocial impairment. Accurate diagnosis requires careful longitudinal assessment, as presentations in youth often differ from adults, with more rapid cycling, mixed features, and irritability over classic euphoric mania. Early diagnosis and treatment are critical to reduce potential impairment and to support early recovery of youth with BD. The purpose of this article is to discuss the use of antipsychotics in the treatment of pediatric BD.

PMID:43051740 | DOI:10.1016/j.chc.2026.07.002

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD